Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following medicine which was referred to the Minister of Health, under the provisions of section 24(5) of the Act, and is set out in the Schedule hereto:
Schedule
Product: Mencevax ACWY vaccine
Active Ingredients: Neisseria meningitidis, group A 50µg
Neisseria meningitidis, group C 50µg
Neisseria meningitidis, group W135 50µg
Neisseria meningitidis, group Y 50µg
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Biologicals SA, Rixensart, Belgium
Dated this 9th day of January 2009.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).